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ABSTRACT
There is a significant and urgent need for affordable, fast, and accurate pathogen
detection methods in resource-limited settings. Currently, accurate pathogen detection methods
are dependent upon special equipment or reagents, specialized training to operate such
equipment, electricity or cold storage, or sterile environments not feasible outside of the
laboratory. Here we present a functionalized cellulose paper device towards an autonomous 3dimensional microfluidics chip to detect bacterial pathogens. The microfluidic device utilizes a
nucleic acid sandwich assay that detects the presence of bacterial RNA through complementary
strand binding. An oligonucleotide “capture strand” immobilizes the targeted RNA sequence to
the device, while a “detection strand” produces a visible colorimetric change due to gold
nanoparticle conglomeration. A smart phone application and camera quantifies the concentration
of the bacterial RNA present in the sample. This detection method can determine concentrations
in the lower limits of the femtomolar range. The microfluidic device was fabricated using wax
printing on cellulose filter paper, which was then folded into a final 3-D configuration. The
simplicity and specificity of this paper-based assay was verified by the detection of E. Coli target
oligonucleotide.
Keywords: 3-Dimensional microfluidic chip, Lab-on-a-Chip, wax printing, oligonucleotides.
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CHAPTER 1: INTRODUCTION
I.

Problem Statement: The Need for ASSURED Bacterial Detection
There is a real and urgent need for better detection methods for bacterial

pathogens. In 2008, the World Health Organization (WHO) published a report stating that
a tenth of the global health burden is caused by unsanitary water [1]. Included in this
statistic are the estimated 3.4 million deaths that occur every year due to waterborne
illnesses [1].

Too often, these deaths arise from inadequate preventative detection

methods for bacterial pathogens. While many methods currently exist to detect these
pathogens, they all fail to meet the WHO’s guidelines for low-cost and deliverable
technologies that can be used on-site in remote locations. These criteria, abbreviated
ASSURED and listed in Table 1, outline the necessary characteristics of a feasible
technology for use in resource-limited areas [2]. Those who live in resource-limited areas
with minimal sanitation have the greatest need for an improved detection method, so any
device that does not meet all of criteria outlined by the WHO is futile in this setting. We
wish to address the alarming health concern of bacterial illnesses globally by developing
an ASSURED device that can detect bacterial pathogens at the point of care in even the
most remote locations.

Those living in at-risk areas will benefit from quicker and

affordable detection of bacteria in water, food, or infections while World Health workers
benefit from easier diagnosis and reduced costs for these tests.
Table 1: ASSURED Criteria. World Health Organization’s ASSURED criteria for point of care devices in
resource-limited areas.

A
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S

U
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E

D

Affordable

Sensitive

Specific

User

Rapid

Equipment-
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Free
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Robust
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CHAPTER 2: LIMITATIONS OF EXISTING TECHNOLOGIES
I.

Reliance upon External Equipment

Currently, accurate pathogen detection methods are dependent upon special
equipment or reagents, electricity or cold storage, or sterile environments not feasible
outside of the laboratory. To address these limitations, devices using nucleic acids to
detect specific gene targets have been implemented with great success; they are valid in a
wide variety of applications, such as food and environmental monitoring and medical
diagnostics.

Methods

of

hybridizing

target

nucleic

acids

to

complementary

oligonucleotides have been studied extensively over the past several decades [3,4].
Nucleic acids are favorable biomarkers because they are specific and sensitive [5], stable
over a wide range of temperatures [6], durable over time [6], and non-toxic. The
advantages of nucleic acid biomarkers address many of the WHO’s ASSURED criteria
including sensitivity, specificity, robustness, and deliverability to end users. Nucleic acids
only bind to complementary strands of oligonucleotides, making the assay incredibly
sensitive and specific for the detection of a chosen bacterial pathogen. A device intended
for use in remote locations must be durable enough to withstand travel to the location
without losing functionality along the way. Because nucleic acids are stable over a wide
range of temperatures and durable over time, they are the ideal sensing platform to be
used in a point-of-care device.
II.

Unsuitable Assay Substrates

Oligonucleotide sandwich assays have been performed on numerous substrates
such as glass [7], hydrogels [8], quantum dots [9], and carbon nanotubes [10]. While each
biomaterial has its own advantages, toxicity and decreased specificity due to small
surface area [11] hinder the implementation of these substrates in point-of-care devices.
For this reason, we propose a paper-based device because cellulose has a high surface
area and is inherently non-toxic [12]. Cellulose is comprised of numerous fibers, which
allow oligonucleotides to bind to the cellulose in 3-dimensions, as opposed to only the 2-

2

dimensional surface of other substrates [11]. The increased surface area enhances the
overall sensitivity of the assay. Cellulose is fundamentally inert, but can be functionalized
with zirconia, which has been shown to covalently link cellulose and oligonucleotides
[11]. Gold nanoparticles (AuNPs) used in sandwich assays performed on zirconia-coated
cellulose can still produce colorimetric results with high sensitivity [7, 13-14].
Additionally, cellulose is the most abundant natural polymer on earth [15], making it one
of the cheapest biomaterials available for use in a medical device. This therefore meets
the affordability criteria outlined by the WHO for a point-of-care device.
III.

Inadequate Analysis Methods

Electrochemical [16], optical [17], and mass-sensitive methods [18] have been
used to detect a binding event between oligonucleotides and the target sequence. While
these methods are accurate and well established, they require additional equipment and
training to operate. Such devices are not practical in resource-limited settings because
laboratories are scarce, and the end-users who need a bacterial detection device may not
know how to use them. Therefore, we move toward an autonomous microfluidic chip that
uses a smartphone and application for analysis. Smart phones are becoming more and
more prevalent in the developing world, and because of this scientists are looking to
bridge the gap between patients and doctors by using smart phones as diagnostic tools
[19]. The cell phone camera takes a picture of the colorimetrically altered substrate; the
picture is then analyzed by a mobile application that can produce quantitative
measurements that cannot be deduced by the naked eye alone [19]. The use of smart
phones in medical diagnostics meet the equipment-free and user-friendly criteria given by
the WHO. Because mobile phones are common and simple to use, patients can easily take
charge of their own health, even in remote locations with limited access to trained
professionals and laboratories.
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CHAPTER 3: NOVEL DESIGN PROPOSAL
I.

Sandwich Assay Platform
Our method of bacterial detection employs a sandwich assay using customized,

single-stranded oligonucleotide sequences that are mimic to bacterial RNA sequences.
Our “Capture” strand, named as such because it will “capture” the bacterial RNA
sequence, is immobilized on cellulose functionalized with a thin, zirconia coating. The
Capture sequence is complementary to the known “Target” sequence of pathogen RNA.
Therefore, the Target strand represents the specific bacterial RNA sequence of the
pathogen we are detecting. For the purposes of this device, we are using a known
sequence unique to E. coli as our Target strand. When the Target bacterial strand binds
to the Capture strand, it is immobilized on the paper substrate. To detect a binding event
between the Capture strand and the Target strand, a third oligonucleotide sequence, called
the “Detection” strand, is then introduced to complete the sandwich assay. The Detection
DNA strand is conjugated with 20nm gold nanoparticles on the 3’ end of the sequence.
When the detection strand binds to the immobilized Capture+Target complex, the
conglomeration of gold nanoparticles produces a red color on the paper.

This

colorimetric change can be difficult distinguish, as the red color is faint. Therefore, silver
enhancement solution is then used to amplify the color change. In the presence of gold
nanoparticles, silver enhancement solution will deposit solid, silver nanoparticles onto the
gold nanoparticles. The papers then turn gray in color, with darkness varying upon the
concentration of the Target strand. A schematic of this assay can be found in Figure 1.
This assay is both sensitive and specific, detecting target concentrations well into the
femtomolar range.

4

Figure 1: Sandwich Assay Design Schematic (1) Cellulose is coated with a thin film of zirconia. (2)
Zirconia-coated cellulose immobilizes Capture DNA. (3) Target DNA binds to Capture DNA. (4)
AuNP/Detection probe completes sandwich assay and (5) is enhanced with silver solution, producing
colorimetric response.

II.

Integrated Platform in Microfluidic Chip
To create a WHO ASSURED device, the sandwich assay platform must be

integrated into an autonomous, user-friendly microfluidic chip. On the lab bench, the
different reagents are added sequentially by hand to produce the desired detection signal.
However, this device is not intended for use in a lab with specialized lab equipment to
carry out the reaction. Therefore, we must engineer a device to automatically carry out all
steps of the sandwich assay so that the device is user friendly, even for an untrained end
user.
Our proposed microfluidic chip will use the fundamentals of paper origami to
construct a 3-dimensional (3D) chip. As presented by Crooks et. al., this paper-folding
technique to fabricate 3D microfluidic chips minimizes costs, and allows for simple and
rapid assembly and unfolding for analysis [20]. The device will be fabricated onto a
single piece of cellulose filter paper, and then folded into the final 3D shape. When a
fluid is introduced to the device, it will flow horizontally due to capillary action, and
vertically due to gravitational force. To guide the fluid movement, hydrophobic regions
and hydrophilic channels will be created. Before folding, we will be able to deposit and
dry the various reagents of the sandwich assay into the channels. We intend to carry out
5

each step of the sandwich assay as the fluid moves from channel to channel, rehydrating
the required assay reagents along the way. A schematic of our proposed chip can be
found in Figure 2.

Figure 2: 2-Dimensional View of Device. The orange layer represents the layer upon which the assay
takes place. This layer is predeposited with zirconia+Capture oligonucleotide and will change color in the
presence of the target strand. The 2 layers above the zirconia piece will contain the Detection strand that
will anneal to the introduced Target strand and then be introduced to the zirconia paper. The layers below
the orange piece will contain the reagents required to carry out silver enhancement to amplify the biosignal
given off by the Detection strand.
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To fabricate our 3D chip, the proposed design of Figure 2 will be wax-printed
onto cellulose filter paper. Wax printing is analogous to inkjet printing except that it
utilizes solid ink blocks as opposed to liquid ink cartridges. The solid wax ink is
hydrophobic, and will not smear when exposed to fluids. Using the ink’s innate
hydrophobicity, we will be able to create hydrophilic channels in which the sample fluid
will flow. As explored by Renault et. al., wax printing has several advantages over other
fabrication methods; wax printing is incredibly fast, allowing hundreds of devices to be
made in a short amount of time, therefore increasing the manufacturability of these
devices [21]. Additionally, wax printing minimizes contamination of the channels
through which fluid will flow, ultimately resulting in a more accurate and reliable device
[21].
The final component of our device will be a case to house the 3D paper substrate.
Using Solidworks, a drawing will be created to be 3D-printed using the standard
Makerbot plastic extruders. The layer upon which the full assay takes place is the third
layer of our proposed design. Therefore, we must design a housing component that will
not have to be taken apart entirely so that the paper can be unfolded to reveal the results
on the third layer. To this end, we will design the third layer to land on a removable part
so that it can be extracted for analysis without disturbing the entire column of layers.
III.

Analysis by Mobile Phone Application
Once the assay is completed and the critical zirconia layer has been removed from

the vertical column, the colorimetric change must be analyzed. We are using a cell phone
camera and mobile application to carry out the analysis because smart phones are
becoming increasingly common in the developing world. The amount of bacteria in a
sample will be quantified by taking a picture of the colorimetrically altered paper. The
mobile phone will analyze the red, green, and blue (RGB) values of each pixel. This pixel
analysis will ultimately produce a quantitative value related to the concentration of
bacteria present in the sample. This mobile phone application gives the end-user the
unique opportunity to take charge of their own health, even when professional medical
resources are limited. This preventative care device has the potential to greatly reduce the
disease

states

caused

by
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unsanitary

water.

CHAPTER 4: PROJECT PLANNING
I. Team Management
To bring this project to fruition, we will be working closely together to ensure that
the work is done accurately and in a timely manner. Each team member will spend
around 6 hours in the lab per week; this amount of time will be required to meet our
proposed goals. During the lab time, both partners will work on both the bench top assay
and integration into the microfluidic device. Both partners do not have to be in the lab at
the same time, but will split the work evenly. For difficult or tricky procedures, both
partners will work together to ensure each protocol is carried out accurately.
Our team will be meeting weekly with our project advisor, Dr. Ashley Kim.
During these meetings, results obtained on a weekly basis will be presented for review.
This time will be used to make appropriate modifications and to answer any questions
that may arise. Outside of our weekly meetings, we will communicate efficiently,
ensuring that Dr. Kim is up to date on our progress. Additionally, meetings will be
scheduled with Dr. Kim and other Santa Clara University faculty members who have
expertise in a given topic. By utilizing these resources, we are more likely to create a
viable and sustainable product.
II. Proposed Timeline
Table 2: Quarterly Goals. List of goals to complete on a quarterly basis. Note that work done in fall 2014
must be validated before the winter and spring goals can be achieved.
Quarter

Goals
Improve AuNP-Detection conjugation methods
Determine viability of silver enhancement solution
Test gold enhancement technique
Research microfluidic chip fabrication methods
Design microfluidic chip
Begin wax printing devices
Test fluid movement through wax-printed devices
Validate DNA movement through device
Dry assay reagents into channels to integrate
sandwich assay into the device
Test enhancement step on device
Present at Senior Design Conference
Complete thesis.

FALL 2014

WINTER 2015

SPRING 2015
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III. Budget
Table 3: Budget. Outline of the expenses of this project. The source of funding is the Roelandt’s Grant,
totally $3900.00
Material
Oligonucleotide Sequences
Xerox wax printer
Wax ink cartridges
Zirconium IV Butoxide
Gold Nanoparticles
Cellulose filter paper
Denhardt’s Solution
Conference Registration
Total Expenses
Roelandt’s Grant

Cost
- $2000.00
- $630.00
- $175.00
- $300.00
- $200.00
- $50.00
- $130.00
- $415.00
- $3900.00
+ 3900.00
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CHAPTER 5: PRELIMINARY RESULTS AND PROTOTYPING
I.

Benchtop Sandwich Assay Analyzed by Mobile Application
Before the final microfluidic prototype is made, the oligonucleotide sandwich

assay needed to be validated on the benchtop to demonstrate the specificity and
sensitivity of the detection platform. To this end, we performed the assay manually
(methods described in chapter 8); in the final design, the manual steps will be integrated
into the chip design so the end-user does not have to carry out any difficult protocols to
produce the results. Ultimately, higher concentrations of the target strand (the
complimentary bacterial DNA strand) will produce the darkest colorimetric change,
while lower concentrations will produce a lighter colorimetric change. To test this theory,
we introduced 1µM-10fM (5 100-fold dilutions and a control) of Target oligonucleotide
to the immobilized zirconia+Capture complex, followed by incubation in the AuNPconjugated Detection strand. Therefore, a gradient of darkness should be visible to the
naked eye, with 1µM paper being the darkest, 1fM paper being the lightest, and the
control showing no color change. The color gradient produced by the assay can be found
in Figure 3.

Figure 3: Camera Phone Images of Completed Sandwich Assay. Images demonstrate the color gradient
produced by varying concentrations of target oligonucleotide.

As seen in Figure 3, the color gradient was visible to the naked eye. However, a
more quantitative analysis of the color change can be garnered using the mobile phone
application. The mobile application is a replacement for a lab microscope, which can
easily analyze colorimetric changes. We intend that this device will be used in a resourcelimited settings where traditional microscopes are unavailable. Therefore, we tested the
validity of the mobile application in comparison to a lab microscope.
10

Figure 4: Microscope and Mobile Image Analysis. Microscope results shown in black and mobile app
results shown in red. Both instruments produce comparable trend line.

From the data shown in Figure 4, the mobile phone application will serve as a reasonable
analysis device for use in resource-limited settings. Relative intensity is a measure of how much
light is present in a given image. Therefore, the lightest paper (the control) has the highest
intensity and so on down to the 1µM concentration. The computer engineering team will

continue to improve the mobile phone application so the trend line of the mobile phone
more closely mimics that of the lab microscope. Given the results of the benchtop
sandwich assay in conjugation with the mobile phone application analysis, we believe
this platform can be successfully integrated into a 3D microfluidic chip.
II.

Microfluidic Chip Fabrication
Upon completion of the sandwich assay validation, we gathered the parts required

to actually fabricate our device. We purchased a wax printer, and have been able to print
our microfluidic chip. We have printed our device onto an 18cm diameter cellulose filter
paper, cut out the unnecessary components, and folded the device into its 3D shape. We

11

have validated the guided fluid movement through the hydrophilic channels by using
dyed water samples. The wax printer ink has proven its hydrophobicity as no traces of
water can be seen in the hydrophobic spaces.

12

CHAPTER 6: EXPECTED RESULTS
I.

Sequential Assay Performed on Self-Contained Microfluidic Chip
Upon validation of the assay platform and directed fluid movement through the

3D wax printed microfluidic chip, we move to integrate the platform onto the chip itself.
The platform can be split up into two distinct phases; the first phase contains the
immobilization of the zirconia+Capture+Target+Detection complex. To do so, we will
dry the various reagents of the assay onto the chip. Introduction of the fluid sample will
rehydrate the reagents so the full assay can take place. In our final fabricated device, we
intend to pre-load the critical zirconia paper with the Capture strand already immobilized,
which will ultimately reduce the time required to complete the assay. Therefore, the
Detection strand will be dried onto a channel, and then will be rehydrated upon
introduction of the Target oligonucleotide. Once rehydrated, we anticipate that the
Detection strand will be able to anneal freely to the target strand and the preloaded
zirconia+Capture complex. Once immobilized onto the zirconia layer, the complex will
be stable for the signal enhancement step.
II.

Signal Production and Enhancement on Microfluidic Chip
Once the zirconia+Capture+Target+Detection complex is immobilized, the

biosignal caused by the gold nanoparticle conjugated to the Detection strand must be
amplified so that analysis can be done using the smart phone application. The silver
enhancement step (see Chapter 7 for methods) includes the mixing of two solutions
before addition to the immobilized complex. Therefore, we will be drying the reagents of
the silver enhancement procedure into the chip channels. We anticipate that these
solutions will mix upon rehydration, and the guided channels will introduce the silver
solution to the immobilized complex from the assay completed in phase one. We expect
that the papers will have a colorimetric change based upon the concentration of the target
strand introduced in phase one comparable to the results seen when the procedure is
carried out on the benchtop (see Figure 3).
13

CHAPTER 7: BACKUP PLANS
I.

Silver Enhancement
In our early work benchtop work with the platform assay, we quickly learned that

the silver enhancement step was not just a simple mixing to two solutions. The silver
enhancing solutions are incredibly reactive, so the reaction step must be carried out with
great precision. Although preventative measures are taken to limit false-positive results,
we found that silver enhancing solution reacts with simple cellulose, and not gold
nanoparticles exclusively. This is of grave concern for our device because it is entirely
cellulose-based. Although we were able to produce clear results with this method, we had
to carefully monitor the reaction time to gauge how long the papers should be exposed to
the silver solution. However, an enhancement step that requires vigilant monitoring and
some extent of scientific discretion may not suitable for a device intended for use by
untrained user. Fu et. al. also experienced the inconsistencies of silver enhancement in his
work with a 2D paper microfluidic chip. As an alternative, his research group utilized a
gold enhancement solution for signal amplification [22]. Instead of the solution causing
silver nanoparticles to precipitate onto gold nanoparticle probes, the gold enhancing
solution causes gold nanoparticles to precipitate onto gold nanoparticle probes. Fu reports
that the gold enhancement solution is much more sensitive and greatly reduces false
positives. If we continue to experience complications with the silver enhancing solution,
we could possible substitute it for gold enhancement solution.
II.

Nanoparticle Conjugation
When the Detection oligonucleotide is synthesized, it is made with a 3’ thiol

modification. Once the thiol is reduced, the gold nanoparticles can be conjugated to the
strand for use in the final component of the sandwich assay. This step has proven difficult
because the 3’ thiol may be very reactive. Therefore, once reduced, the thiol may oxidize
quickly with any exposure to oxygen. In our early research, we experienced many
difficulties trying to conjugate the nanoparticles to the Detection strand, which could
likely be caused by inert thiol due to oxidization. The biosignal-emitting Detection strand
is integral to the completion of our device as we can do no testing or analysis without it.
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Therefore, if we cannot successfully conjugate the nanoparticles to the Detection strand,
we can have the Detection strand synthesized with a 3’ C3 fluorescein modification. This
strand would be analogous to the nanoparticle-conjugated strand, but the biosignal can
only be seen under a microscope and cannot be enhanced by silver or gold enhancing
solutions. Although this is not an ideal substitution, it would allow us to track the
movement of the various assay components through the microfluidic chip. Ideally, the
fluorescein labeled Detection strand could move through the chip and ultimately
immobilize on the zirconia layer; therefore, if the immobilization occurs, the zirconia
layer should glow under the microscope. A device that requires a lab microscope for
analysis is not suitable for use in a resource-limited setting, but it could at least validate
that the assay itself will work on a microfluidic chip.
III.

On-Chip Enhancement - Proof of Concept
If the detection strand cannot be successfully conjugated with gold nanoparticles

consistently, we will be unable to determine if silver or gold enhancement can occur on a
paper microfluidic chip; the enhancing solution is unable to deposit silver precipitates
onto a C3 fluorescein modification. Until the conjugation step is perfected, we could still
test the viability of on-chip signal enhancement. In this case, we will spot nanoparticles
onto a zirconia-coated cellulose paper and let it dry. We would then deposit and dry the
various solutions required for the enhancement into the channels of the microfluidic chip.
Upon rehydration with water, we expect the reagents will all mix appropriately to
precipitate the silver nanoparticles onto the dried gold nanoparticles. We would vary the
concentrations of gold nanoparticles dried onto the zirconia layer in hopes of seeing a
clear grayscale gradient much like the results we saw in the benchtop assay (see figure 3).
The enhancement step is vital to produce a signal that can be analyzed by the mobile
application; this step can still be validated by these methods even if we cannot
successfully conjugate gold nanoparticles to the detection oligonucleotide.
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CHAPTER 8: MATERIALS AND METHODS
I.

Materials
Oligonucleotides used in the testing and validation of the sandwich assay were

obtained from Elim Biopharmaceuticals Inc (Hayward, CA). Gold nanoparticles that
were later conjugated to the Detection oligonucleotides were purchased from SigmaAldrich, Inc (St. Louis, MI). The zirconia utilized to functionalize the cellulose paper for
DNA binding was obtained from Sigma-Aldrich, Inc (St. Louis, MI). Denhardt’s
Solution, a component of the non-specific binding buffer, was also obtained from
Invitrogen (Grand Island, NY). Dithiothreitol (DTT), which was used to reduce the thiol
on the 3’ end of the Detection oligonucleotide, was purchased from Sigma Aldrich, Inc
(St. Louis, MI). The silver enhancement kit used to amplify the AuNP biosignal was
obtained from Sigma-Aldrich, Inc (Saint Louis, MI).

Salmon sperm DNA, another

component of the non-specific binding buffer, was obtained from Thermo Fisher
Scientific (Santa Clara, CA). The gold enhancement kit, used to amplify the AuNP
biosignal, was obtained from Nanoprobes Inc (Yaphank, NY).

Concentrations of

oligonucleotide solutions were determined using the NanoDrop UV-Vis Spectroscopy
(Wilmington, DE). Fluorescent imaging was conducted using the Olympus BX51WI
epifluorescent microscope, and QCapture Pro6.0 software was used to characterize the
fluorescence of the samples.
II.

Benchtop Sandwich Assay Validation
a. Deposition of Zirconia
Zirconia was cyclically deposited onto cellulose filter paper as described by Xioa

and Huang [23]. In summary, filter paper was placed into a pump-powered filtration
apparatus. To begin the first cycle, the filter paper was washed thoroughly with ethanol.
Then, 10mL of zirconia were added to the filtration funnel. The zirconia was left standing
for 5 minutes, and then pulled through the filter for 3 minutes. The paper was then
washed and filtered with sufficient water, which washes away any unreacted zirconia. To
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complete the cycle, the paper was washed thoroughly with ethanol. This 5-step cycle was
repeated 10 times to obtain a thin but visible layer of zirconia on the filter paper.
b. Immobilization of Capture Oligonucleotide
The Capture oligonucleotide was then bound to the cellulose+zirconia substrate at
the 5’ terminus through a 24-hour submersion of the cellulose+zirconia substrate in the
oligonucleotide. Capture strands tagged with C3-Fluorescein at the 3’ terminus were
synthesized with a fluorophore modification. The binding of the Capture+tag strands to
the substrate was then visualized using fluorescent microscopy to determine the optimal
concentration of capture bound to the paper. Zirconia+cellulose substrates were then
incubated with untagged, optimal concentration capture strands for 24 hours, washed
with water, and then air dried. To prevent nonspecific binding to the cellulose+zirconia
substrate, the cellulose+zirconia+Capture complex was bathed in a pre-hybridization
solution (Denhardt’s solution, 0.1M salmon sperm DNA). The substrates were then
washed in 10mM, 1mM Tris-EDTA buffer and air dried [23].
c. Immobilization of Target Oligonucleotide onto Zirconia+Capture
Complex
Target oligonucleotides were introduced at varying concentrations to the
cellulose+zirconia+Capture substrates. Target sequences tagged with a CAL Flour Red
610 modification at the 5’ terminus were imaged to verify the binding to the substrate
using fluorescent microscopy. The lower limit of detection of the target was determined
[23]. Once the limit of detection was determined, untagged Target oligonucleotide was
introduced to zirconia+Capture complex in varying concentrations ranging from 1µM to
10fM. The zirconia+Capture complex was incubated with the target strand for 24 hours
and then washed with water and air dried.
d. Detection Nanoparticle Conjugation
The Detection oligonucleotide was synthesized with 3’ thiol modification to allow
for gold nanoparticle conjugation. The dried Detection probe was resuspended in at
100mM DTT solution for 1 hour. The Detection strand was then purified through G25
columns. Gold nanoparticles were prepared by centrifugation at 13,200 rpm for twenty
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minutes. The supernatant fluid was removed, and the nanoparticles were incubated with
dATP in a ratio of 1000:1 dATP:AuNP for 15 minutes. The purified detection was then
added to the dATP/AuNP mixture in a ratio of 1:500 AuNP/dATP:detection
oligonucleotide. The probes were then left on a shaker at 60℃ for three hours, and then
left to incubate on the benchtop for 2 hours at room temperature. After incubation, the
probes were centrifuged and washed with 100mM phosphate buffer at pH 8.5. This wash
step was repeated 3 times, and the probe was stored in 100µL of 0.3M NaCl, 10mM PBS
with pH 8.0 at 4℃ [24].
e. Introduction of Detection Sequence
The gold nanoparticle conjugated Detection probe was then incubated with the
zirconia+Capture+Target complex at 2µM for 90 minutes. The papers were then washed
with water and bathed in 0.5M EDTA at pH 4.5 to prevent nonspecific signal
enhancement. They were then washed with water again and left out to dry for 30 minutes.
f. Signal Enhancement
The silver enhancement solution was prepared by mixing equal volumes of
Solution A and Solution B. The papers with the zirconia+Capture+Target+Detection
complex were then incubated in the mixed solution for approximately 8 minutes followed
immediate by a bath in Silver Stabilizer Solution. Finally, the papers were washed with
water and dried for analysis.
g. Assay Analysis under Microscope and Mobile Application
To quantitatively analyze the colorimetric signal produced in the enhancement
step, papers were visualized under a fluorescent microscopy. Using ImageJ software, the
relative intensity of the color was measured. A smart phone with an attachable
microscope piece took pictures of each paper, and also produced the relative color
intensity. The values given by the software and mobile phone application were compared
to validate the mobile phone application.
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III.

Microfluidic Chip Fabrication
a. Chip Design, Printing, and Heating
The microfluidic chip was designed using Microsoft Powerpoint. Once the image

was made, it was wax printed onto 18 cm filter paper. The filter paper was then heated on
a hot plate at 100℃ for approximately 8 minutes to allow the wax to melt into the
cellulose. The unnecessary filter paper was cut away and the device was folded into its
3D shape.
IV.

Integrating Sandwich Assay with Microfluidic Chip
a. Determining Time Constraints and Volume Requirements
To transition the sandwich assay into the device itself, the time required for

incubation and the volume of fluid required to run through the device must be
determined. To this end, various volumes of colored fluid were introduced to the device
to determine the minimum volume needed to reach the inner detection layer of the
device. After this volume was determined, the time it took for the minimum volume to
reach the detection layer was recorded.
b. Validation of DNA Movement through the Device
For the proposed device design to function properly, the oligonucleotides must be
able to move through the device. The oligonucleotides are carried in the fluid horizontally
due to capillary action, and vertically through gravitational force. A small zirconia-coated
cellulose strip (~4mm x 4mm) with immobilized Capture oligonucleotide (see chapter
7.II.B for methods) was placed onto the detection pad. The required layers of the device
were folded on top of the critical detection layer. Small weights that did not interfere with
the device channels were laid atop the 3D device to compress the various layers of the
device and to stabilize the zirconia+Capture substrate in its position. Following
stabilization, 40µL of varying Target+tag oligonucleotide sequences were pipetted into
the first channel of the device. The devices were left to incubate overnight
(approximately 17 hours). After incubation, the zirconia+Capture+Target+tag papers
were washed thoroughly with water and left to dry. Once the papers were dry, they were
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analyzed using the fluorescent microscopy and ImageJ software. The device itself was
also viewed under fluorescent microscopy to further view how the fluorescent
oligonucleotides traveled through the device layers.
Once the oligonucleotide movement through the device was validated using
fluorescently tagged oligonucleotides, the above procedure was repeated. However,
untagged Target oligonucleotides were introduced to the first channel as opposed to the
Target+tag sequences. After incubation, the papers were washed with sufficient water
and bathed in EDTA to prevent non-specific binding. The papers were then incubated in
2µM Detection oligonucleotide for 90 minutes. Following incubation, the papers were
washed with water and placed into gold enhancement solution for 2 hours. After the
enhancement step, the papers were washed with water and left to dry. When papers were
dry, the colorimetric change was analyzed using fluorescent microscopy and ImageJ
software.
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CHAPTER 9: RESULTS
I.

Capture+Tag Verification

Figure 5: Capture+Tag Fluorescent Images. Fluorescent images taken of cellulose+zirconia papers with
immobilized Capture+Tag oligonucleotides. Based on qualitative analysis, the brightness of the
fluorescence increases as the Capture oligonucleotide concentration increases.
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Figure 6: Capture+Tag Image Analysis. Numerical analysis of fluorescence brightness garnered from the
fluorescent microscope and ImageJ software. This quantitative analysis demonstrates that the fluorescent
intensity increases with increasing Capture+Tag oligonucleotide concentration. The 7.5µM and 15µM
concentrations have similar intensities, suggesting the papers become saturated with oligonucleotide in this
region.

II.

Target+Tag Verification

Figure 7: Target+Tag Fluorescent Images. Oligonucleotides were added at varying concentrations to
zirconia+Capture strands. From qualitative observation, the brightness of the fluorescence increases with
increasing Target+Tag oligonucleotide concentration.
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III.

Gold Enhancement Verification

Figure 8: Completed Sandwich Assay. Quantitative measure of the darkness of
zirconia+Capture+Target+Detection paper substrates after soaking in gold enhancement solution. Gold
enhancement solution increases the effective radius of the gold nanoparticles conjugated to the Detection
strand, changing the paper color from red to purple. As the Target oligonucleotide concentration increases,
the papers become darker, therefore decreasing the relative intensity.

IV.

Target+Tag Movement through Device Demonstration

Figure 9: DNA Flow through Device. Fluorescent Target+Tag DNA was passed through the device to
land on zirconia+capture paper substrates. A) Fluorescent image of zirconia+Capture substrate to which no
Target+Tag DNA was introduced through the device, therefore yielding minimal fluorescence. B)
Fluorescent image of zirconia+Capture substrate to which 5µM Target+Tag DNA was introduced through
the device, ultimately producing a fluorescent signal. C) Image of one channel of the microfluidic device,
showing that the fluorescent DNA moves through the device channels. D) Image of a second channel of the
device, also demonstrating the movement of DNA through the device.
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V.

Target Movement through device Followed by Detection-AuNP
incubation and Gold Enhancement

Figure 10: Completed Sandwich Assay after DNA Flow through Device Images and quantitative
analysis of Target DNA ran through the device to land on zirconia+Capture paper substrate. Following
incubation, the papers were washed and incubated with the Detection probe. The papers were then washing
and bathed in gold enhancement solution. The images and numerical data show that darkness of the paper
increases with increasing Target oligonucleotide concentration.
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CHAPTER 10: DISCUSSION
I.

Assay Platform
a. Capture+Tag Validation
In our final device proposal, we intended to manufacture the zirconia-coated

detection layer with the Capture strand immobilized onto it. With this initial step done in
the manufacturing process, the Capture strand is prepared to anneal to the target bacterial
RNA as soon as it is introduced. Therefore, we needed to determine an optimal
concentration of Capture oligonucleotide to immobilize onto the zirconia-coated
cellulose. To determine this concentration, we incubated the zirconia-coated papers with
varying concentrations of Capture+Tag oligonucleotides. The 5’ phosphate groups
covalently bonded to the positively charged zirconia surface. The 3’ end was modified
with C3 Fluorescein, which fluoresces a bright green color. In these trials, the 3’ end is
not bound to any other substrates so the fluorescence can be easily analyzed.
In Figure 6, the images appear to fluoresce with more intensity as the
concentration of Capture+Tag increases. Because the papers have a limited surface area,
there is a limited concentration of Capture that can be bound to them. We aimed to
determine an ideal Capture concentration that was larger that the upper limit of the RNA
we would be testing in the second assay step (1µM), but was small enough to produce
consistent results without wasting materials in manufacturing. In Figure 6, the
fluorescence of the 7.5 µM and 15 µM Capture concentrations were comparable.
Therefore, we determined that we would load the zirconia-coated cellulose papers with
10 µM of Capture DNA for all future testing. 10 µM is well above our upper limit of
detection, meaning there is enough Capture strands bound to the paper to immobilize the
largest concentration of Target oligonucleotide we planned to test in the second step of
the assay.
b. Target+Tag Validation
To validate the second step of the sandwich assay, the Target oligonucleotide
strands were synthesized with a 5’ CAL RED 610 modification. We hypothesized that the
3’ end of the oligonucleotide would anneal to the complementary Capture strand already
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immobilized on the zirconia-coated cellulose substrate. Therefore, the 3’ end containing
the fluorescent modification would be unbound to any other substrates, allowing us to
analyze the fluorescence accurately. We anticipated that the brightness of the fluorescent
images would increase with increasing concentration of Target oligonucleotide. As seen
in Figure 6, the 10 fM concentration fluoresces the least, and the brightness intensifies
leading up to the 1 µM concentration.
To quantitatively analyze the fluorescent intensity, the fluorescent microscope and
ImageJ software was used to produce numerical values of the intensity. Our qualitative
analysis was affirmed with the quantitative data seen in Figure 7; the relative intensity,
which is the measure of brightness in an image, increases with increasing concentrations
of Target oligonucleotide.
Demonstrating a fluorescent gradient was a critical step in our research.
Ultimately, we not only wanted our device to detect the presence of bacterial RNA in a
sample, but we wanted to determine to what degree the bacteria is present. This step
demonstrated that the assay was sensitive enough to distinguish one Target strand
concentration from another.
c. Gold Enhancement Validation
In a resource-limited settings, fluorescent microscopes are unavailable to use for
the detection of bacterial pathogens. Therefore, the third strand of the sandwich assay
was synthesized to create an optical signal when a binding event occurred between the
Capture and Target strands. The Detection strand binds to the Capture+Target complex
on its 5’ end, leaving the 3’ end conjugated with gold nanoparticle free. The signal
produced by the nanoparticles alone is not strong enough to been seen and analyzed by
the naked eye. Therefore, the papers are soaked in gold enhancement solution to darken
the original signal. We anticipated that the gold enhancement step would produce a
gradient similar to the gradient obtained by the fluorescent microscopy. As seen in Figure
8, the papers become darker with increasing concentration of Target oligonucleotide.
This therefore confirms that the Detection strand conjugated with gold nanoparticles can
accurately detect varying concentrations of Target oligonucleotide present in a sample.
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In our original design proposal and preliminary results, we were using silver
enhancement solution as opposed to gold enhancement solution. We quickly learned that
the silver enhancement solution is highly reactive. The silver did not react with gold
nanoparticles exclusively, as the silver would precipitate onto control groups that
contained no gold nanoparticles. After producing many false-positives, we switched our
signal amplification method to gold enhancement. Gold enhancement works similarly to
silver enhancement; instead of precipitating silver particles onto the gold nanoparticles
conjugated to the Detection strand, the solution precipitates gold nanoparticles. The gold
nanoparticles we conjugate to the detection strand have a 20 nm diameter and are red in
color. As the radius of the gold nanoparticles increases, the color changes to purple and to
blue. When the gold enhancement solution precipitates gold nanoparticles onto the
existing gold nanoparticles, the effective radius of the original probes increases.
Therefore, the darkest colorimetric change caused by high Target oligonucleotide
concentrations appears purple. In our testing, we have seen that gold enhancement
solution significantly decreases the chance of producing false positives and the solutions
are more selectively reactive.
II.

Chip Fabrication
Fabricating our device using wax printing is incredibly simple, therefore

increasing the manufacturability of our product. The cellulose filter paper can be fed into
the printer directly, allowing us to make dozens of devices within an hour. The printer
only patterns the design onto one side of the filter paper, so the wax must be melted
through the paper and on to the other side. To do this, we placed the patterned filter paper
onto a hot plate, face up. The melting process must be monitored vigilantly because the
wax does run when heated. Therefore, we saw that the widith of the channels would
decrease, and sometimes completely close off if the paper is left on the hot plate too long.
After fabricating many devices, the average device takes about 8-10 minutes to melt the
wax onto the reverse side of the filter paper at 100℃ without closing the channels.
III.

On-Chip Assay and Enhancement
a. Target+Tag Movement through Device
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The assay steps involving fluorescent analysis and gold enhancement have all
been done on the bench top in our lab. However, this device is intended for use in the
developing world, so the assay must be integrated into the device itself in order for our
methods to be valid in a resource limited setting. The first step to integrating the assay
was to demonstrate that the oligonucleotide strands could travel through the device layers
to land on the detection layer containing the Capture strand immobilized on the zirconiacoated cellulose. To show the movement of DNA through the device, we ran the
Target+Tag oligonucleotide through two channels leading to a small piece of
zirconia+Capture paper placed into the detection layer. Because this step was a proof of
concept, we first ran fluid containing no Target DNA through the device as seen in Figure
9A. We then ran a 40µL of 5 µM Target oligonucleotide through the device as seen in
Figure 9B. After the incubation time, the paper was washed with water, dried, and viewed
under the fluorescent microscope. By comparing Figure 9A and 9B, we have shown that
oligonucleotides will move travel both horizontally through channels and vertically onto
subsequent layers.
Figure 9C and 9D show the two channels the Target+Tag strand traveled through.
Both of these images show some degree of fluorescence, indicating that there is
Target+Tag DNA remaining in the channels. The channels were not washed before
imaging so that we could verify that the DNA did in fact travel through every portion of
each channel.
b. Target Movement through Device Followed by Benchtop Detection
Incubation and Gold Enhancement
After demonstrating the movement of DNA through the device, we aimed to
produce a colorimetric gradient visible to the naked eye using varying concentrations of
Target oligonucleotide to run through the device. Following incubation with the Target
oligonucleotides, the zirconia+Capture+Target paper substrates were removed from the
detection layer. They were incubated with the third Detection sequence, and were then
incubated in gold enhancement solution. As seen in Figure 10, a gradient can be seen
qualitatively and is affirmed by the quantitative analysis by the microscope. This step
further verified that the assay is sensitive enough to detect varying concentrations of the
Target DNA even when it is run through the device as opposed to incubating on the
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benchtop. We did notice that the gold enhancement reaction took a great while to produce
gold precipitates to change the color of the papers. Typically, this reaction takes minutes
but this step took about 2 hours to complete. The control in this trial was not entirely
white, suggesting that the enhancement solution has non-specifically precipitated gold
nanoparticles that were not removed in the wash steps. Even though the control turned
color slightly, it was still lighter than the lowest concentration we tested for (Figure 10).
In this step, we chose to use higher concentrations of Target DNA than usual
because we were uncertain of how much Target DNA was going to be lost while moving
through the channels. On the benchtop, we have shown that the assay can detect into the
femtomolar range. Future work on this device will work to achieve the same sensitivity
through the device as there is on the benchtop.
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CHAPTER 11: PROJECT SUMMARY
I.

Objectives and Milestones
a. Project Scope
Our research demonstrates important advances in the long-term scope of this

project.

Our role focused on validating the nucleic acid assay, improving the

enhancement steps, and developing a prototype for the microfluidic device.
We began working on this project in 2014. At this time, nobody had been
working on this research at Santa Clara for about a year. Therefore, our initial stages of
research involved restarting the research. Table 4 shows the overall scope of the project
and our role in it (shown in bold).
Table 4: Project Timeline and Scope. Our contributions are bolded.

Project Task
Project Inception
Preliminary Research
Initial Assay Testing & Validation
Assay Refinement
Device Fabrication
Device Integration
Field Testing
Project Completion

Timeline
2012
2012
2012 & 2014
2014
2015
2015-Future
Future
Future

b. Objectives
Our initial objective for this project was to have a functioning prototype of the
microfluidic device. Quickly, we realized that this projection was overly ambitious, and
we adjusted our objectives to reach attainable milestones. Table 5 shows our completed
and uncompleted milestones in this project.
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Table 5: Project Milestones

Milestone
Date Completed
Verify Capture Binding
July 2014
Verify Target Binding
July 2014
Conjugate DNA with AuNP
August 2014*
Verify completed sandwich assay
August 2014*
Design microfluidic device
January 2015
Test fluid flow on microfluidic device
April 2015
Verify DNA flow through device layers
May 2015
Test dried reagents on device
May 2015
Develop on-device lysis method
Future
Test device with bacterial cells
Future
Field test device for constraints
Future
* DNA/AuNP conjugation was not reproducible until February 2015
II.

Design Evaluation
a. Positives
The microfluidic device that we have produced has numerous positive attributes

that make it a promising avenue for future work.

It is design to detect bacterial

pathogens, and we have demonstrated that it can accomplish this task. Through both
fluorescent imaging and colorimetric change, we have verified sensitive nucleic acid
binding that corresponds to known bacterial RNA sequences.
Not only does the design detect bacterial pathogens, it does so while meeting most
of the ASSURED criteria for a diagnostic device. Our current prototype costs around $3
or $4 dollars, making it affordable. The nucleic acid assay is both sensitive and specific.
The design of the device is user-friendly because it requires minimal sample-loading and
easy to interpret results. The device is also equipment free, as it can be used with or
without a mobile phone. All these aspects of the device make it deliverable to the end
user.
b. Negatives
One challenge that has been associated with this device has been producing
consistently reliable results. Occasionally, the gold nanoparticles will color the control
paper, confounding the results. This issue with the design has been mitigated with
control steps, such as rinsing the papers with EDTA to further prevent non-specific
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binding. Gold enhancement has also improved the consistency of the results, as opposed
to previous methods which used silver enhancement instead. This issue of reliability is a
challenge in the design, but one that can be addressed with further testing and
optimization of reagent concentrations.
III.

Future Work
a. Assay Reproducibility
The sandwich assay is the fundamental platform of the device, and therefore must

produce accurate results from trial to trial. In the early stages of our research, we had
difficulty reproducing results from trial to trial. Through fluorescent microscopy, we
were able to see that the Capture and Target strands were binding to their respective
locations properly. The issues usually arose in the conjugation of gold nanoparticles to
the Detection oligonucleotide. Without properly conjugated nanoparticles, the Detection
strand cannot accurately detect the binding event between the Capture and Target strands.
After much discussion with Dr. Korin Wheeler of the biochemistry department, we
pinpointed the error we were making in the conjugate synthesis. The thiol on the 3’ end
of the Detection strand will oxidize quickly after the initial reduction protocol. Therefore,
the nanoparticles must be added to the reduced Detection strand immediately to force the
reduced thiol to bind to the nanoparticles as opposed to oxidizing again. Towards the end
of our project, we were able to make suitable AuNP-Detection conjugates that accurately
detected the binding event between the Capture and Target sequences. The next team of
researchers who picks up this project will need to verify our results by synthesizing more
conjugates that produce a clear, colorimetric gradient when varying concentrations of
Target oligonucleotide are added to the zirconia+Capture paper substrates.
b. Dried DNA/AuNP on device
Because we have been able to demonstrate that DNA will move through the
device, the next step in integrating the assay into the device is to dry the AuNP-Detection
conjugates into the device channels. The AuNP-Detection strand can be dried in the
channel right before the detection layer. When the Target oligonucleotide is introduced to
the device, we anticipate that the fluid will rehydrate the dried Detection strand. Ideally,
the AuNP-Detection strand will anneal to the Target oligonucleotide within this device
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channels, and ultimately travel to the detection layer containing the zirconia+Capture
paper substrate.
c. Bacterial Lysis on Device
The focus of our research was on the development of the nucleic acid assay and
device manufacturing. This focus meant that we wanted to be as exact as possible in
verifying the binding events for each stage of the assay. Therefore, instead of using RNA
from lysed bacterial cells, we used synthesized oligonucleotide sequences that were
mimetic of the in vivo RNA. Approaching the project in this way meant better control
over our design experiments, but also meant that our research did not exactly simulate the
conditions in which the device will be used.
Since we used synthesized sequences for the Target bacterial strand, we did not
need to use bacterial cells during our research, which by extension meant that we did not
need to lyse bacterial cells. In future work, bacterial cell lysis will be an important step
in device use. We anticipate that a lysis step will be integrated into our device, and will
probably be the first stage of the device reactions. Current literature in cell lysis suggests
that chemical methods may be a viable solution. Depositing detergents, such as SDS, on
the device during production may be able to lyse the samples sufficiently to expose the
RNA to the external environment. Further research will be required to determine which
chemicals to use, how much, and how they may affect subsequent reactions and DNA
binding.
d. Gold Enhancement on Device
We have demonstrated that gold enhancement of gold nanoparticles is a reliable
method of signal clarification for our device. This method requires the combination of
four different solutions – two combined for five minutes, followed by subsequent serial
addition of the following two solutions – in equal volumes. While this is simple to
perform in a lab, the conversion of such protocol to a device requires more attention.
Tests need to be performed that the reagents can be dried on the paper and successfully
rehydrated while retaining functionality. Furthermore, the concentrations of the solutions
may need adjustment to account for material lost while the volumes run through the
device; earlier reactions steps need to travel farther than later steps, so higher
concentrations will likely be needed to account for the loss. Our current design includes
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prototypical designs for the fluid flow of the gold enhancement solutions, but further
testing will be required to optimize the reaction timing and concentration balances.
e. Assay Validation with Bacterial RNA
As mentioned in the “Bacterial Lysis on Device” section, we have been using synthesized
DNA sequences to emulate the bacterial RNA which we will actually be testing for in
real life applications. Therefore, future work will require that bacteria cells be cultured
and RNA be extracted. Once the RNA is isolated from the bacterial cells, the sandwich
assay will need to be tested using this RNA, as opposed to the sequenced Target strands
which we have used thus far.
f. Field Testing
Once all the reaction steps have been transferred to the device and reliable results
have been generated, field testing will be required to determine the practicality and
constraints to the device. Important factors, such as the shelf life, temperature range,
humidity conditions, and numerous other environmental factors must be tested before the
devices can be considered practical for field use. Since an important aspect of our device
design is to make it meet ASSURED criteria, comprehensive field testing will be vital to
optimize the device.
IV.
Design Validity
The principles upon which our design is based are well-established. Paper-based
microfluidics is an established field. Nucleic acid reactions are thoroughly categorized
and validated as sensitive and specific detection methods. Our design repurposes these
well-defined fields in a novel way that promises to be a valid approach to a serious global
health issue. At this stage in our research, we have no reason to believe that the design is
invalid.
V.
Design Constraints
Our project has many strengths in the design that make it adaptable and applicable in
numerous settings; however, there are certain limiting factors that are associated with the
inherent characteristics of our device design.
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a. Liquid Phase
This project uses microfluidics to carry out the biological reactions on the device.
Inherently, this approach requires that the samples being tested be in a liquid phase.
Therefore, solid or gaseous samples cannot be analyzed using our device. These phases
cannot pass through the layers of the device, and the dried reagents on the layers will not
be functionalized unless rehydrated with a liquid of near-neutral pH. A possible solution
to this issue is to dissolve samples in a simple liquid, such as water, and then add that
solution to the device. However, it is possible that with some samples this would be very
difficult or impossible. In such situations, our device would not be an appropriate
solution for bacterial detection.
b. Simple solutions
A key step in our microfluidic device is the fluid flow throughout the device. If
the sample being tested is very complex, viscous, highly acidic or alkaline, or at extreme
temperatures, then the functionality of our device may be constrained. The fluid sample
needs to be hydrophilic in order to flow through the cellulose channels, and it needs to be
of a low viscosity in order to ensure fluid flow. Complex solutions may hinder bacterial
lysis and interfere with the reaction steps later in the device. Extreme pH, salt balances,
or temperature may affect the molecular structure of the DNA sequences and impair the
functionality of the device. The constraints that these factors place on the device may be
mitigated since such extreme conditions may make bacterial survival unlikely as well.
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CHAPTER 12: ETHICAL CONSIDERATIONS
I. Ethical Considerations
The motto for Santa Clara’s School of Engineering is “Engineering with a
mission”, which emphasizes the importance of using technical skills to benefit society.
This focus demands a deep understanding of the ethical implications that accompany our
project. The goal of our work is to address the unequal access to diagnostic medical
devices between resource-rich and resource-limited areas. By developing a low-cost
microfluidic device that detects bacterial pathogens, we aim to breach the gap between
life-saving technology and those who need it most. Through the lens of “A Framework
for Thinking Ethically” provided by Santa Clara’s Markkula Center for Applied Ethics,
we will analyze the ethical justification, embedded impact, and decision-making process
involved in our project.

Figure 11: Deaths Caused by Contaminated Water. World Health Organization’s 2002 report mapping
the numbers of deaths worldwide caused by water/sanitation/hygiene (WSH) related diseases.[25]
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II. Ethical Justification
a. Utilitarian Justification
In 2014, approximately 2,300 men, women, and children died every day as a
result of unsanitary conditions.[26]

Similar deaths and illnesses could be avoided by

rapid and reliable diagnostic tests to determine the safety of water, food, or other possible
contaminated sources. Quicker identification prevents prolonged exposure to bacterial
pathogens and improved overall health for the individuals and communities at risk.
Therefore, better diagnostic tools lead to more efficient health care, which saves lives and
lowers medical costs for patients and professional health care services.
b. Rights & Responsibilities Justification
The United Nations’ Universal Declaration of Human Rights states in Article 3
that “everyone has the right to life, liberty, and security of the person.” Yet, the rights to
life and basic health care are not being adequately met on a global scale. Millions of
people are made sick by contaminated water every year, and they often do not know the
cause of the illness until it is too late. By providing quality diagnostic devices to
communities in need, we can prevent pathogenic illness and save lives. In doing this, we
uphold our ethical responsibility to preserve the dignity of others and respect their rights
to life and health.
c. Justice & Fairness Justification
750 million people are exposed to unsafe drinking water worldwide, with a vast
majority of these people living in Africa and Asia.[27] This limited accessibility leads to
improper hygiene, ultimately creating a heightened risk of bacterial infection.

The

unequal distribution of resources and basic health care disproportionately harms
impoverished communities. Our device can quickly detect the presence, identity, and
quantity of pathogens, therefore contributing to medical care and illness prevention. We
aim to serve justice by providing fair and equal access to our device by making it low
cost. Despite income inequalities and disparities in access to resources, our device
promises high-quality diagnostics that are affordable to resource-limited areas.
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d. Common Good Justification
The old expression “an ounce of prevention is worth a pound of cure” holds
especially true when dealing with health care. Healthier people cost healthcare systems
less and contribute to society more. Therefore, society benefits as a whole when disease
is reduced. The targeted development of our device towards the marginalized not only
helps the patients themselves, but also contributes to the common good of the community
and society as a whole.

As referenced in the Santa Clara Engineering Handbook,

bioethics expert Daniel Callahan emphasizes “replacing the current ‘ethic of individual
rights’ with ‘an ethic of the common good’” in order to address the health care concerns
in our modern world.

Our device serves the common good because the whole

community benefits from the knowledge of what water, food, or environmental hazards
to avoid.
e. Virtue Justification
The Biomedical Engineering Society sets forth a Code of Ethics that guides us to
be good and just biomedical engineers. It obligates us to use our knowledge to “enhance
the safety, health, and welfare of public” as well as “strive by action, example, and
influence to increase the competence, prestige, and honor of the biomedical engineering
profession.” This two-fold obligation not only compels us to be competent engineers, but
also to form our character as leaders for good. Adopting these virtues has compelled us
to take on a project that improves the quality of life for the users of our device.

III. Embedded Concerns & Decision-Making
a. Utilitarian Embedded Concerns & Decision-Making
To maximize the positive outcomes of this research, proper prioritization is
necessary when allocating funds, time, and energy. Optimizing the balance of these
resources is crucial to accelerating the project and bringing it closer to the end user.
Additionally, this project must be the best option for bacterial diagnostics in resourcelimited areas to be ethically justified. If at any point a better technology arrives that
outperforms this, then we must reevaluate the project and redirect it to maximally provide
good.
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b. Rights & Responsibilities Embedded Concerns & Decision-Making
In addition to our responsibility to protect the basic human rights, we have
responsibilities to address these concerns in the right way.

This includes our

responsibility to maintain proper Health and Safety standards while employing
environmentally conscious and sustainable practices.

Our device uses non-toxic

chemicals, so it is safe to manufacture and produce for those involved in the fabrication
process.

Furthermore, our device uses cellulose as the substrate, which is

environmentally friendly, especially when compared to alternative plastic materials that
often involve production methods hazardous to both workers and the environment. After
use, our devices can be cleanly burned, which eliminates waste without contributing to
pollution.
Ensuring proper and reliable use is another important aspect of our project. We
must be sure to properly test and validate the device to eliminate possible false-negatives
and false-positives, as inaccurate readings may result in the end user being at risk.
Accompanying this concern is the matter of usability. If this device can practically be
used by communities globally, it must be simple and durable to serve real-world
applications. Keeping these responsibilities in mind, we have taken the extra time to
validate every step and develop the device before using it outside of the lab.
c. Fairness and Justice Embedded Concerns & Decision-Making
If the device is used fairly and justly, it can help marginalized groups have better
control over their health and safety. However, a concern is the proper distribution of this
device to ensure that those in need have access to it. By partnering with global non-profit
organizations, such as the WHO, we aim to avoid the commoditization of the technology.
At the same time, economic considerations must be taken to ensure continued production
of the device and proper wages for the workers involved in this process. Striking the
balance between keeping the device affordable and respecting workers and the
environment is a fine line, and partnering with the WHO or UN could help facilitate this
balance.
d. The Common Good Embedded Concerns & Decision-Making
Serving the common good means contributing to the interlocking relationships of
society. As mentioned earlier, the diagnostic device must be made equally accessible for
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the sake of justice, but the common good depends on that distribution as well. Foreigners
bringing in new technologies to communities may cause division within communities or
complete rejection of the technology if the interaction is not conducted with respect.
Also, it is possible some members of communities may seek to leverage access to this
device for power or money, which would harm the common good even more. Therefore,
we must develop a model of distribution that respects local customs and values while still
effectively reaching the targeted users. This may come in the form of working with local
health professionals who have both medical training and cultural ties to the communities.
e. Virtue Approach Embedded Concerns & Decision-Making
Charles Harris’ article “The Good Engineer: Giving Virtue Its Due in Engineering
Ethics” addresses certain virtues that good engineers must have to address concerns in the
field. These include techno-social sensitivity, respect for nature, commitment to the
public good, teamwork, and courage. It is not enough for an engineer to create one
ethical project, if he or she will then abandon those ethics in the sake of serving selfinterest. Rather, a virtuous engineer is informed by society’s needs and acts in a way that
serves the larger public good. Additionally, any project undertaken will take into account
the impact it will have on nature. While these decisions may not always be easy, a
virtuous engineer will never hesitate to take the hard road if it is the right road.

IV. Conclusion
We aim to address the global issue of illnesses caused by bacterial contamination
through the development of a low-cost diagnostic device that could be used in resourcelimited areas globally (summarized in Table 6).

Identifying and quantifying

contaminated sources can improve medical professional’s ability to treat illnesses, as well
as prevent them. As a result, human dignity and right to life are upheld. By producing the
device at a low cost we preserve justice because all people will have equal access. Proper
manufacturing methods will protect the environment and respect the rights of workers.
As the device is used, it will gradually lead to healthier communities, contributing to the
common good. If all these steps are taken with care and ethical leadership, then the
greatest good will be done for the greatest number of people.
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Table 6: Ethical Analysis. Breakdown of Ethical Framework for low-cost bacterial diagnostic device

Justification

Embedded Concerns Decision-Making

Utilitarianism

Better diagnostic
tools contribute to
preventing disease

Alternative
technologies may
solve the issue
better

Stay informed about
other research and
technology to ensure
that our device
develops in a way that
best meets healthcare
needs

Rights &
Responsibilities

We have
responsibilities as
engineers to protect
human dignity and
life

1. Environmental
Responsibility in
manufacturing and
disposal of device.
2. Responsibility to
create safe work
environment for
those who assemble
the device

1. Use cellulose as
substrate because it is
cost-effective, safe, and
environmentally
friendly.
2. Construct ethical
business model that
respects rights of
workers

Justice & Fairness

Our devices are
affordable and
therefore accessible
to resource-limited
communities

Proper distribution
and delivery of the
device in resourcelimited settings

Partner with global
health organizations,
such as the WHO or
UN, to use their
expertise in delivering
the technology to those
in need

Common Good

Healthy
communities are
more prosperous,
and provide a better
quality of life

Proper use of device
is required to
actually help the
end-users

Design user-friendly
device that is intuitive
and practical for realworld settings across
cultures

Virtue

Good biomedical
engineers
demonstrate values
that serve society,
such as integrity and
compassion

Staying informed
about society’s
needs and
consistently acting
in an upright and
ethical manner

Collaborate with
respected colleagues to
further develop ethical
character and decisionmaking skills
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CHAPTER 13: CONCLUSION
The research presented in this report is foundational for the future growth of this
device. We were posed with the challenge of creating a bacterial detection device that
could be used in the developing world because current methods fail to meet the WHO’s
ASSURED criteria. With these criteria in mind, we have developed a platform to detect
bacterial pathogens in solution. We demonstrated that an oligonucleotide sandwich assay
is specific and sensitive enough to detect varying concentrations of Target
oligonucleotide. We have fabricated a microfluidic chip that carefully controls the
movement of fluids, allowing for future integration of the detection assay onto the device.
The direction of this research is promising, as our current data has validated the device
components to this point. Future work built on the research we have complied thus far
promises to achieve the goal of an ASSURED device for bacterial pathogen detection.
Table 7: ASSURED Components of Device. Evaluation of our bacterial detection method against the
WHO’s ASSURED criteria.

A

S

S

U

R

Affordable

Sensitive

Specific

UserFriendly

Rapid
and
Robust

Paperbased

Can
determine
varying
concentrations of
Target

Oligonucleotide
sandwich
assay to
test for
specific
bacterial
pathogens

E

Equipment Deliverable
Free
to End
Users

AutonoDevice
Smart
mous
materials phone and
microfluidic
applicatidevice
on used
for
analysis
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D

Durable,
manufacturabl device.
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APPENDICES
Oligonucleotide Sequences
Sequence Name

Nucleotide Sequence 5’-3’

Modifications

Capture

TTT GTC AAT GAG CAA AGG T

5’ Phosphate Addition

Capture+Tag

TTT GTC AAT GAG CAA AGG T

5’ Phosphate Addition,
3’ C3 Fluorescein

Target

GGG GAG GAA GGG AGT AAA GTT

None

AAT ACC TTT GCT CAT TGA C
Target+Tag

GGG GAG GAA GGG AGT AAA GTT

5’ CAL Flour Red 610

AAT ACC TTT GCT CAT TGA C
Detection

TAC TCC CTT CCT CCC CTT TTT TTT
TT

A-1

3’ Thiol Addition

Cost Calculations: Material costs based on purchased
Materials

Cost per Device

Cellulose

$0.001

Zirconia

$1.00

Capture DNA

$0.60

Detection DNA

$0.50

Gold Nanoparticles

$1.40

Wax

$0.01

Gold Enhancement

$1.25

ESTIMATED COST per

$4.76

DEVICE

A-2

Materials
Material

Item Number

Vendor

Location

Gold Nanoparticles

741965

Sigma Aldrich

St. Louis, MI

Zirconia

771600

Sigma Aldrich

St. Louis, MI

Denhardt’s Solution

750018

Invitrogen

Grand Island, NY

DTT

D9779

Sigma Aldrich

St. Louis, MI

Silver Enhancement

A: S5020

(Solutions A & B)

B: S5145

Sigma Aldrich

St. Louis, MI

Salmon Sperm DNA

15632011

Invitrogen

Grand Island, NY

2115

Nanoprobes

Yaphank, NY

Gold Enhancement
Kit

A-3

